WC @Sanctuary_Bio · 01 Sep 2026
so let's see...TYK2 questionable at best in lupus, and in terms of modality, CAR-T needs tweaks. What has promise here...B Cell depletion not in CAR-T...like perhaps a mAB or bispecific...
4 430Views
25Likes
1Reposts
3Replies
0Quotes
6Bookmarks
Is that a lot?
0.73×vs this author's median6 032 views is typical
17Percentile for this authorof 6 recent posts
1.31×vs 10K–100K median3 383 views is typical
39.89%Reachviews ÷ followers
0.66%Engagement rateof viewers reacted